Results 121 to 130 of about 51,607 (296)

The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study [PDF]

, 1993
K B Miller, K. Kyungmann, Francis S. Morrison, Jane N. Winter, John M. Bennett, Richard S. Neiman, David R. Head, Peter A. Cassileth, M J O'Connell   +8 more
openalex   +1 more source

The Efficacy of Pediatric‐Inspired Regimens vs. Hyper‐CVAD in the Treatment of Adolescents and Young Adults With Acute Lymphoblastic Leukemia: A Systematic Review and Meta‐Analysis

American Journal of Hematology, Volume 100, Issue 5, Page 847-859, May 2025.
ABSTRACT Adults with acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL) have poorer outcomes than pediatric patients. The aim of this systematic literature review and meta‐analysis was to compare asparaginase (ASP)‐containing pediatric‐inspired regimens (PIRs) with hyper‐fractionated cyclophosphamide, vincristine, doxorubicin, and ...
Wenqing Su, Melisa Stricherz, Alison Martin, Jonathan Belsey, Eric Kemadjou, Daniel J. DeAngelo   +5 more
wiley   +1 more source

Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia [PDF]

, 1992
Gary J. Schiller, James Gajewski, Mary Territo, S D Nimer, Myung Lee, T Belin, R Champlin   +6 more
openalex   +1 more source

Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management

American Journal of Hematology, Volume 100, Issue 5, Page 860-891, May 2025.
ABSTRACT Disease Overview Acute myeloid leukemia (AML) is a bone marrow stem cell cancer that is often fatal despite available treatments. Diagnosis, risk assessment, monitoring, and therapeutic management of AML have changed dramatically in the last decade due to increased pathophysiologic understanding, improved assessment technology, and the ...
Shai Shimony, Maximilian Stahl, Richard M. Stone   +2 more
wiley   +1 more source

The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia clinical results in 46 patients [PDF]

, 1993
Enrica Morra, Mario Lazzarino, Ercole Brusamolino, G. Pagnucco, Carlo Castagnola, Paolo Bernasconi, Ester Orlandi, Alessandro Corso, Alberto Santagostino, Carlo Bernasconi   +9 more
openalex   +1 more source

Long‐Term Outcomes and Management Strategies With DA‐R‐EPOCH in Primary Mediastinal B‐Cell Lymphoma: Insights From a Single‐Center Experience

Hematological Oncology, Volume 43, Issue 3, May 2025.
ABSTRACT Immunochemotherapy has demonstrated high cure rates in primary mediastinal large B‐cell lymphoma (PMBCL). Recent findings from the IELSG 37 study show that certain specific dose‐dense treatment regimens are more likely to eliminate the need for consolidative radiation therapy, thereby reducing long‐term toxicity. Here, we report our experience
Robin Noel, Catalina Montes de Oca, Patrick Sfumato, Anne Calleja, Aude Collignon, Ferdinand Villetard, Jean Marc Schiano de Collela, Frédéric Benizri, Pilar Dutari, Cécile Castoldi, Faezeh Izadifar‐Legrand, Luca Inchiappa, Catherine Evans, Gabriel Brisou, Lenaig Mescam, Vincent Camus, Thibaut Reichert   +16 more
wiley   +1 more source

Detection of cytarabine resistance in patients with acute myelogenous leukemia using flow cytometry [PDF]

, 1994
Francis Lacombe, Françis Belloc, Patrice Dumain, M. Puntous, PC Makhoul, MC Saux, Philippe Bernard, MR Boisseau, Josy Reiffers   +8 more
openalex   +1 more source

Multi‐Omic Evaluation of PLK1 Inhibitor—Onvansertib—In Colorectal Cancer Spheroids

Journal of Mass Spectrometry, Volume 60, Issue 5, May 2025.
ABSTRACT Polo‐like kinase 1 (Plk1) is a serine/threonine kinase involved in regulating the cell cycle. It is activated by aurora kinase B along with the cofactors Borealin, INCE, and survivin. Plk1 is involved in the development of resistances to chemotherapeutics such as doxorubicin, Taxol, and gemcitabine.
Brian D. Fries, Emily R. Sekera, Joseph H. Holbrook, Amanda B. Hummon   +3 more
wiley   +1 more source

Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia [PDF]

, 1992
Wiernik Ph, PL Banks, DC Jr Case, Arlin Za, PO Periman, MB Todd, PS Ritch, RE Enck, AB Weitberg   +8 more
openalex   +1 more source

Acute Myeloid Leukaemia With Morphologic and Immunophenotypic Differentiation to Acute Erythroid Leukaemia at the Time of Relapse

International Journal of Laboratory Hematology, EarlyView.
Katie Liston, Vitaliy Mykytiv
wiley   +1 more source